These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5846409)

  • 21. Histochemical pattern of tetrahydrofolate dehydrogenase in hemopoietic cells following folate antagonist treatment in vivo.
    Nano R; Gerzeli G; Gervaso MV; De Piceis Polver P; Arisi C
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(3):191-7. PubMed ID: 498204
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase.
    Jackson RC; Niethammer D
    Eur J Cancer (1965); 1977 Jun; 13(6):567-75. PubMed ID: 880964
    [No Abstract]   [Full Text] [Related]  

  • 23. Vriation of dihydrofolate reductase activity in mammalian cells in vitro.
    Hillcoat BL; Bertino JR
    Exp Cell Res; 1969 Aug; 56(2):304-8. PubMed ID: 5259181
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patients.
    Dedhar S; Hartley D; Fitz-Gibbons D; Phillips G; Goldie JH
    J Clin Oncol; 1985 Nov; 3(11):1545-52. PubMed ID: 3863895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductase.
    Drake JC; Allegra CJ; Chabner BA
    Biochem Pharmacol; 1986 Apr; 35(7):1212-4. PubMed ID: 3964298
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
    Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
    Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
    [No Abstract]   [Full Text] [Related]  

  • 27. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
    Domin BA; Cheng YC; Hakala MT
    Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960
    [No Abstract]   [Full Text] [Related]  

  • 28. Coordinated changes in biochemical patterns: the effect of cytosine arabinoside and methotrexate on leukocytes from patients with acute granulocytic leukemia.
    Roberts D; Hall TC; Rosenthal D
    Cancer Res; 1969 Mar; 29(3):571-8. PubMed ID: 5251290
    [No Abstract]   [Full Text] [Related]  

  • 29. An isotopic assay for dihydrofolate reductase.
    Roberts D
    Biochemistry; 1966 Nov; 5(11):3549-51. PubMed ID: 4382039
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for a genetic alteration of dihydrofolate reductase associated with amethopterin resistance in Diplococcus pneumoniae.
    Sirotnak FM; Donati GJ; Hutchison DJ
    Biochem Biophys Res Commun; 1964; 14():292-5. PubMed ID: 4378682
    [No Abstract]   [Full Text] [Related]  

  • 31. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for two molecular species of dihydrofolate reductase in amethopterin resistant and sensitive cells of the mouse leukemia L4946.
    Blumenthal G; Greenberg DM
    Oncology; 1970; 24(3):223-9. PubMed ID: 5418574
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
    Black KA; Tephly TR
    Mol Pharmacol; 1983 May; 23(3):724-30. PubMed ID: 6865915
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity.
    Canellos GP; Mead JA; Greenberg NH; Schrecker AW
    Cancer Res; 1967 Apr; 27(4):784-8. PubMed ID: 4225918
    [No Abstract]   [Full Text] [Related]  

  • 35. Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.
    Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1972 Jul; 32(7):1539-46. PubMed ID: 4402276
    [No Abstract]   [Full Text] [Related]  

  • 36. In search of a key.
    Roberts D
    Natl Cancer Inst Monogr; 1971 Dec; 34():118-30. PubMed ID: 4946577
    [No Abstract]   [Full Text] [Related]  

  • 37. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect and istribution of methotrexate in the human organism during leukemia treatment].
    Wilmanns W; Martin H
    Klin Wochenschr; 1968 Mar; 46(6):281-96. PubMed ID: 5245556
    [No Abstract]   [Full Text] [Related]  

  • 39. Amplified dihydrofolate reductase genes are localized to a homogeneously staining region of a single chromosome in a methotrexate-resistant Chinese hamster ovary cell line.
    Nunberg JH; Kaufman RJ; Schimke RT; Urlaub G; Chasin LA
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5553-6. PubMed ID: 281704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate deficiency and in vitro palatogenesis II: Effects of methotrexate on rabbit palate fusion, folate pools, and dihydrofolate reductase activity.
    DePaola DP; Mandella RD
    J Craniofac Genet Dev Biol; 1984; 4(4):321-7. PubMed ID: 6520212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.